| Literature DB >> 33082187 |
Gunnar Husabø1,2, Roy Miodini Nilsen3, Erik Solligård4,5, Hans Kristian Flaatten6, Kieran Walshe7, Jan C Frich8, Gunnar Tschudi Bondevik2,9, Geir Sverre Braut10,11, Jon Helgeland12, Stig Harthug13,14, Einar Hovlid15,2,11.
Abstract
OBJECTIVE: To evaluate the effects of external inspections on (1) hospital emergency departments' clinical processes for detecting and treating sepsis and (2) length of hospital stay and 30-day mortality.Entities:
Keywords: accident & emergency medicine; audit; change management; health & safety; health policy; infectious diseases
Mesh:
Year: 2020 PMID: 33082187 PMCID: PMC7577024 DOI: 10.1136/bmjopen-2020-037715
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Key elements of the intervention
| Time in months | Activity |
| 1 | Inspection team announces inspection and requests the hospital to submit information |
| 2 | Inspection team reviews records of patients with sepsis and collect relevant data for the inspection criteria. Data are collected for two time periods, baseline (September 2015) and right before the site visit. Inspection team reviews information from hospital and prepares for the site visit |
| 3 | Two-day site visit at the hospital with interviews of key personnel |
| 4–5 | The inspection team writes a preliminary report of their findings. The hospital can comment on the report |
| 6 | The inspection team sends the final report to the hospital |
| Continuously | The hospital plans and implements improvement measures |
| 11 | Follow-up audit (8 months after site visit). The inspection team reviews records of patients with sepsis and collect the same kinds of data as they did prior to the site visit |
| 17 | Follow-up audit (14 months after site visit). The inspection team reviews records of patients with sepsis and collect the same kinds of data as they did prior to the site visit. |
Figure 1Trial profile.
Figure 2Patient flow.
Patient characteristics
| Factor | Before inspection | After inspection | P value | |
| N | 3813 | 3594 | ||
| Sex | Male | 1939 (50.9%) | 1881 (52.3%) | 0.2* |
| Female | 1874 (49.1%) | 1713 (47.7%) | ||
| Age, years | Median (IQR) | 70 (56–81) | 73 (60–82) | <0.001† |
| Mean (SD) | 66.8 (18.8) | 68.9 (18.5) | ||
| Organ failure | 1387 (36.6%) | 1409 (39.3%) | 0.015* | |
| Charlson Comorbidity Index | Median (IQR) | 2 (1–4) | 2 (1–4) | 0.49† |
*Pearson’s χ2 test.
†Wilcoxon rank-sum test.
Figure 3Process measures before and after inspection.
Patient outcomes before and after inspection
| Before | After | Adjusted for background variables* | Adjusted for background and time† | |
| All-cause mortality, | 424 (11.1%) | 377 (10.5%) | 0.81 (0.69 to 0.95)‡ | 1.25 (0.86 to 1.80) ‡§ |
| Length of stay in days, mean (SD) | 7.1 (7.8) | 6.2 (6.1) | 0.87 (0.84 to 0.90)¶ | 0.94 (0.86 to 1.03)¶ |
| n | 3813 | 3594 | 7371 | 7371 |
*Adjusted for age, organ dysfunction, sex and Charlson Comorbidity Index.
†Adjusted for secular trends entered as categorical variables per year, plus the other background variables.
‡OR.
§n=7360.
¶Incidence rate ratio.